BRCA1 and breast cancer: In contrast, FANCI c.1813C>T was the only variant identified in 1/63 (1.6%) familial CDN BRCA1 and BRCA2 pathogenic variant negative BC cases (Fig. 3c, Additional file 1: Table S9) and the carrier was known to be of Greek Canadian origin.